Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1977 Jan;126(1):14–31.

Cell-Mediated Immunity and Its Role in Resistance to Infection

Edward J Wing 1, Jack S Remington 1
PMCID: PMC1237425  PMID: 318786

Abstract

The recently acquired knowledge of the importance of cell-mediated immunity in many illnesses and the discovery of a variety of substances that can restore certain cell-mediated immune functions has served to focus the attention of physicians on this area of immunity. It is important for practicing physicians to have a clear understanding of current knowledge of the role of cell-mediated immunity in resistance to infection and how this arm of the immune system relates to the diagnosis and therapy of infectious diseases.

Full text

PDF
14

Images in this article

16Figure 1.
on p.16
17Figure 2.
on p.17
17Figure 3.
on p.17
19Figure 4.
on p.19
20Figure 5.
on p.20

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson S. E., Jr, Remington J. S. Effect of normal and activated human macrophages on Toxoplasma gondii. J Exp Med. 1974 May 1;139(5):1154–1174. doi: 10.1084/jem.139.5.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arden M. J., Rottino A. Hodgkin's disease complicated by tuberculosis. A twenty-year experience. Am Rev Respir Dis. 1966 May;93(5):810–815. [PubMed] [Google Scholar]
  3. Arvin A. M., Yeager A. S., Merigan T. C. Effect of leukocyte interferon on urinary excretion of cytomegalovirus by infants. J Infect Dis. 1976 Jun;133 (Suppl):A205–A210. doi: 10.1093/infdis/133.supplement_2.a205. [DOI] [PubMed] [Google Scholar]
  4. August C. S., Rosen F. S., Filler R. M., Janeway C. A., Markowski B., Kay H. E. Implantation of a foetal thymus, restoring immunological competence in a patient with thymic aplasia (Digeorge's syndrome). Lancet. 1968 Dec 7;2(7580):1210–1211. doi: 10.1016/s0140-6736(68)91693-0. [DOI] [PubMed] [Google Scholar]
  5. BECH V. Measles epidemics in Greenland. Am J Dis Child. 1962 Mar;103:252–253. doi: 10.1001/archpedi.1962.02080020264013. [DOI] [PubMed] [Google Scholar]
  6. Balow J. E., Hurley D. L., Fauci A. S. Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations. J Clin Invest. 1975 Jul;56(1):65–70. doi: 10.1172/JCI108080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Balow J. E., Rosenthal A. S. Glucocorticoid suppression of macrophage migration inhibitory factor. J Exp Med. 1973 Apr 1;137(4):1031–1041. doi: 10.1084/jem.137.4.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bassi L., Di Berardino L., Arioli V., Silvestri L. G., Lignière E. L. Conditions for immunosuppression by rifampicin. J Infect Dis. 1973 Dec;128(6):736–744. doi: 10.1093/infdis/128.6.736. [DOI] [PubMed] [Google Scholar]
  9. Berry C. L., Thompson E. N. Clinico-pathological study of thymic dysplasia. Arch Dis Child. 1968 Oct;43(231):579–584. doi: 10.1136/adc.43.231.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Blanden R. V. Mechanisms of recovery from a generalized viral infection: mousepox. 3. Regression infectious foci. J Exp Med. 1971 May 1;133(5):1090–1104. doi: 10.1084/jem.133.5.1090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Blanden R. V. Mechanisms of recovery from a generalized viral infection: mousepox. I. The effects of anti-thymocyte serum. J Exp Med. 1970 Nov;132(5):1035–1054. doi: 10.1084/jem.132.5.1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Blanden R. V. Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells. J Exp Med. 1971 May 1;133(5):1074–1089. doi: 10.1084/jem.133.5.1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Blanden R. V. T cell response to viral and bacterial infection. Transplant Rev. 1974;19(0):56–88. doi: 10.1111/j.1600-065x.1974.tb00128.x. [DOI] [PubMed] [Google Scholar]
  14. Bodey G. P., Hersh E. M., Valdivieso M., Feid R., Rodriguez V. Effects of cytotoxic and immunosuppressive agents on the immune system. Postgrad Med. 1975 Dec;58(7):67–74. doi: 10.1080/00325481.1975.11714222. [DOI] [PubMed] [Google Scholar]
  15. Brooks W. H., Netsky M. G., Normansell D. E., Horwitz D. A. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med. 1972 Dec 1;136(6):1631–1647. doi: 10.1084/jem.136.6.1631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Brown S. M., Stimmel B., Taub R. N., Kochwa S., Rosenfield R. E. Immunologic dysfunction in heroin addicts. Arch Intern Med. 1974 Dec;134(6):1001–1006. [PubMed] [Google Scholar]
  17. Bruce D. L., Wingard D. W. Anesthesia and the immune response. Anesthesiology. 1971 Mar;34(3):271–282. doi: 10.1097/00000542-197103000-00017. [DOI] [PubMed] [Google Scholar]
  18. Buchanan R. D., Fine D. P., Colley D. G. Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. II. Pathology and altered pathogenesis. Am J Pathol. 1973 May;71(2):207–218. [PMC free article] [PubMed] [Google Scholar]
  19. Burdick J. F., Wells S. A., Jr, Herberman R. B. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions. Surg Gynecol Obstet. 1975 Nov;141(5):779–794. [PubMed] [Google Scholar]
  20. Capron A., Dessaint J. P., Capron M., Bazin H. Specific IgE antibodies in immune adherence of normal macrophages to Schistosoma mansoni schistosomules. Nature. 1975 Feb 6;253(5491):474–475. doi: 10.1038/253474a0. [DOI] [PubMed] [Google Scholar]
  21. Chandra R. K. Fetal malnutrition and postnatal immunocompetence. Am J Dis Child. 1975 Apr;129(4):450–454. doi: 10.1001/archpedi.1975.02120410038013. [DOI] [PubMed] [Google Scholar]
  22. Churchill W. H., Rocklin R. R., Moloney W. C., David J. R. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity. Natl Cancer Inst Monogr. 1973 May;36:99–106. [PubMed] [Google Scholar]
  23. Cleveland W. W., Fogel B. J., Brown W. T., Kay H. E. Foetal thymic transplant in a case of Digeorge's syndrome. Lancet. 1968 Dec 7;2(7580):1211–1214. doi: 10.1016/s0140-6736(68)91694-2. [DOI] [PubMed] [Google Scholar]
  24. Cloninger P., Thrupp L. D., Granger G. A., Novey H. S. Immunotherapy with transfer factor in disseminated coccidioidal osteomyelitis and arthritis. West J Med. 1974 Apr;120(4):322–325. [PMC free article] [PubMed] [Google Scholar]
  25. Criswell B. S., Butler W. T., Rossen R. D., Knight V. Murine malaria: the role of humoral factors and macrophages in destruction of parasitized erythrocytes. J Immunol. 1971 Jul;107(1):212–221. [PubMed] [Google Scholar]
  26. Daniels J. C., Warren K. S., David J. R. Studies on the mechanism of suppression of delayed hypersensitivity by the antischistosomal compund niridazole. J Immunol. 1975 Nov;115(5):1414–1421. [PubMed] [Google Scholar]
  27. Doherty P. C., Zinkernagel R. M. H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. J Exp Med. 1975 Feb 1;141(2):502–507. doi: 10.1084/jem.141.2.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Doherty P. C., Zinkernagel R. M. T-cell-mediated immunopathology in viral infections. Transplant Rev. 1974;19(0):89–120. doi: 10.1111/j.1600-065x.1974.tb00129.x. [DOI] [PubMed] [Google Scholar]
  29. Dunmire C., Ruckdeschel J. C., Mardiney M. R., Jr Suppression of in vitro lymphocyte responsiveness to purified protein derivative by measles virus. A reexploration of the phenomenon. Cell Immunol. 1975 Dec;20(2):205–217. doi: 10.1016/0008-8749(75)90098-2. [DOI] [PubMed] [Google Scholar]
  30. Dunmire C., Ruckdeschel J. C., Mardiney M. R., Jr Suppression of in vitro lymphocyte responsiveness to purified protein derivative by measles virus. A reexploration of the phenomenon. Cell Immunol. 1975 Dec;20(2):205–217. doi: 10.1016/0008-8749(75)90098-2. [DOI] [PubMed] [Google Scholar]
  31. Eltringham J. R., Kaplan H. S. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease. Natl Cancer Inst Monogr. 1973 May;36:107–115. [PubMed] [Google Scholar]
  32. Emödi G., O'Reilly R., Müller A., Everson L. K., Binswanger U., Just M. Effect of human exogenous leukocyte interferon in cytomegalovirus infections. J Infect Dis. 1976 Jun;133 (Suppl):A199–A204. doi: 10.1093/infdis/133.supplement_2.a199. [DOI] [PubMed] [Google Scholar]
  33. Fauci A. S., Dale D. C., Balow J. E. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976 Mar;84(3):304–315. doi: 10.7326/0003-4819-84-3-304. [DOI] [PubMed] [Google Scholar]
  34. Fine D. P., Buchanan R. D., Colley D. G. Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. I. Eosinophilia and immunologic responses to a schistosomal egg preparation. Am J Pathol. 1973 May;71(2):193–206. [PMC free article] [PubMed] [Google Scholar]
  35. Fireman P., Friday G., Kumate J. Effect of measles vaccine on immunologic responsiveness. Pediatrics. 1969 Feb;43(2):264–272. [PubMed] [Google Scholar]
  36. Fletcher J., Mather J., Lewis M. J., Whiting G. Mouth lesions in iron-deficient anemia: relationship to Candida albicans in saliva and to impairment of lymphocyte transformation. J Infect Dis. 1975 Jan;131(1):44–50. doi: 10.1093/infdis/131.1.44. [DOI] [PubMed] [Google Scholar]
  37. Frenkel J. K. Adoptive immunity to intracellular infection. J Immunol. 1967 Jun;98(6):1309–1319. [PubMed] [Google Scholar]
  38. Frenkel J. K., Nelson B. M., Arias-Stella J. Immunosuppression and toxoplasmic encephalitis: clinical and experimental aspects. Hum Pathol. 1975 Jan;6(1):97–111. doi: 10.1016/s0046-8177(75)80111-0. [DOI] [PubMed] [Google Scholar]
  39. GENDEL B. R., ENDE M., NORMAN S. L. Cryptococcosis; a review with special reference to apparent association with Hodgkin's disease. Am J Med. 1950 Sep;9(3):343–355. doi: 10.1016/0002-9343(50)90430-x. [DOI] [PubMed] [Google Scholar]
  40. Gaines J. D., Gilmer M. A., Remington J. S. Deficiency of lymphocyte antigen recognition in Hodgkin's disease. Natl Cancer Inst Monogr. 1973 May;36:117–121. [PubMed] [Google Scholar]
  41. Gelfand E. W., Biggar W. D., Orange R. P. Immune deficiency: evaluation, diagnosis, and therapy. Pediatr Clin North Am. 1974 Nov;21(4):745–776. doi: 10.1016/s0031-3955(16)33060-7. [DOI] [PubMed] [Google Scholar]
  42. Goldstein A. L., Cohen G. H., Rossio J. L., Thurman G. B., Brown C. N., Ulrich J. T. Use of thymosin in the treatment of primary immunodeficiency diseases and cancer. Med Clin North Am. 1976 May;60(3):591–606. doi: 10.1016/s0025-7125(16)31900-9. [DOI] [PubMed] [Google Scholar]
  43. Gross L., Manfredi O. L., Protos A. A. Effect of cobalt-60 irradiation upon cell-mediated immunity. Radiology. 1973 Mar;106(3):653–655. doi: 10.1148/106.3.653. [DOI] [PubMed] [Google Scholar]
  44. Górski A. J., Dupont B., Hansen J. A., Good R. A. Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro. Proc Natl Acad Sci U S A. 1975 Aug;72(8):3197–3200. doi: 10.1073/pnas.72.8.3197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Han T., Sokal J. E. Lymphocyte response to phytohemagglutinin in Hodgkin's disease. Am J Med. 1970 Jun;48(6):728–734. doi: 10.1016/s0002-9343(70)80008-0. [DOI] [PubMed] [Google Scholar]
  46. Hart P. D., Russell E., Jr, Remington J. S. The compromised host and infection. II. Deep fungal infection. J Infect Dis. 1969 Aug;120(2):169–191. doi: 10.1093/infdis/120.2.169. [DOI] [PubMed] [Google Scholar]
  47. Hodge F. A., Leif W. R., Silverman M. S. Susceptibility to infection with Pasteurella tularensis and the immune response of mice exposed to continous low dose rate gamma radiation. J Infect Dis. 1969 Sep;120(3):356–365. doi: 10.1093/infdis/120.3.356. [DOI] [PubMed] [Google Scholar]
  48. Hong R., Horowitz S. Editorial: Thymosin therapy creates a "Hassall"(?) N Engl J Med. 1975 Jan 9;292(2):104–105. doi: 10.1056/NEJM197501092920213. [DOI] [PubMed] [Google Scholar]
  49. Hughes W. T., Feldman S., Aur R. J., Verzosa M. S., Hustu H. O., Simone J. V. Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer. 1975 Dec;36(6):2004–2009. doi: 10.1002/cncr.2820360912. [DOI] [PubMed] [Google Scholar]
  50. Ichiki A. T., Parish C. R. Cleavage of bacterial flagellin with proteolytic enzymes. II. Induction of enhanced delayed-type hypersensitivity to flagellin by peptic fragments of the protein. Cell Immunol. 1972 Jul;4(3):264–278. doi: 10.1016/0008-8749(72)90030-5. [DOI] [PubMed] [Google Scholar]
  51. Jonsson V. Technical aspects of the rosette technique for detecting human circulating B and T lymphocytes. Normal values and some remarks on null lymphocytes. Scand J Haematol. 1974;13(5):361–369. [PubMed] [Google Scholar]
  52. Jordan G. W., Fried R. P., Merigan T. C. Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection. J Infect Dis. 1974 Jul;130(1):56–62. doi: 10.1093/infdis/130.1.56. [DOI] [PubMed] [Google Scholar]
  53. Jordan G. W., Merigan T. C. Enhancement of host defense mechanisms by pharmacological agents. Annu Rev Pharmacol. 1975;15:157–175. doi: 10.1146/annurev.pa.15.040175.001105. [DOI] [PubMed] [Google Scholar]
  54. Joris F., Girard J. P. Immune response in aged and young subjects, following administration of large doses of tuberculin. Int Arch Allergy Appl Immunol. 1975;48(5):584–596. doi: 10.1159/000231347. [DOI] [PubMed] [Google Scholar]
  55. Kaplan J. Effect of x-irradiation on induction of delayed hypersensitivity as measured by in vitro macrophage migration inhibition. J Reticuloendothel Soc. 1972 Jul;12(1):90–95. [PubMed] [Google Scholar]
  56. Kataria Y. P., Sagone A. L., LoBuglio A. G., Bromberg P. A. In vitro observations on sarcoid lymphocytes and their correlation with cutaneous energy and clinical severity of disease. Am Rev Respir Dis. 1973 Oct;108(4):767–776. doi: 10.1164/arrd.1973.108.4.767. [DOI] [PubMed] [Google Scholar]
  57. Kaufman H. E., Meyer R. F., Laibson P. R., Waltman S. R., Nesburn A. B., Shuster J. J. Human leukocyte interferon for the prevention of recurrences of herpetic keratitis. J Infect Dis. 1976 Jun;133 (Suppl):A165–A168. doi: 10.1093/infdis/133.supplement_2.a165. [DOI] [PubMed] [Google Scholar]
  58. Kint A., Verlinden L. Letter: Levamisole for recurrent herpes labialis. N Engl J Med. 1974 Aug 8;291(6):308–308. doi: 10.1056/NEJM197408082910614. [DOI] [PubMed] [Google Scholar]
  59. Kleinerman E. S., Snyderman R., Daniels C. A. Depressed monocyte chemotaxis during acute influenza infection. Lancet. 1975 Nov 29;2(7944):1063–1066. doi: 10.1016/s0140-6736(75)90432-8. [DOI] [PubMed] [Google Scholar]
  60. Krahenbuhl J. L., Rosenberg L. T., Remington J. S. The role of thymus-derived lymphocytes in the in vitro activation of macrophages to kill Listeria monocytogenes. J Immunol. 1973 Oct;111(4):992–995. [PubMed] [Google Scholar]
  61. Krahenbuhl J. L., Ruskin J., Remington J. S. The use of killed vaccines in immunization against an intracellular parasite: Toxoplasma gondii. J Immunol. 1972 Feb;108(2):425–431. [PubMed] [Google Scholar]
  62. LOURIA D. B., FALLON N., BROWNE H. G. The influence of cortisone on experimental fungus infections in mice. J Clin Invest. 1960 Sep;39:1435–1449. doi: 10.1172/JCI104163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Lagrange P. H., Mackaness G. B., Miller T. E. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med. 1974 Jun 1;139(6):1529–1539. doi: 10.1084/jem.139.6.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Lane F. C., Unanue E. R. Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med. 1972 May 1;135(5):1104–1112. doi: 10.1084/jem.135.5.1104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Law D. K., Dudrick S. J., Abdou N. I. Immunocompetence of patients with protein-calorie malnutrition. The effects of nutritional repletion. Ann Intern Med. 1973 Oct;79(4):545–550. doi: 10.7326/0003-4819-79-4-545. [DOI] [PubMed] [Google Scholar]
  66. Lefford M. J., McGregor D. D., Mackaness G. B. Immune response to Mycobacterium tuberculosis in rats. Infect Immun. 1973 Aug;8(2):182–189. doi: 10.1128/iai.8.2.182-189.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Louria D. B., Hensle T., Armstrong D., Collins H. S., Blevins A., Krugman D., Buse M. Listeriosis complicating malignant disease. A new association. Ann Intern Med. 1967 Aug;67(2):260–281. doi: 10.7326/0003-4819-67-2-261. [DOI] [PubMed] [Google Scholar]
  68. MACKANESS G. B. Cellular resistance to infection. J Exp Med. 1962 Sep 1;116:381–406. doi: 10.1084/jem.116.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. MASCIA A. V., CHICK F. E., LEVY W. E. Effects of rubeola on tuberculosis. J Pediatr. 1953 Sep;43(3):294–296. doi: 10.1016/s0022-3476(53)80402-6. [DOI] [PubMed] [Google Scholar]
  70. MacCuish A. C., Urbaniak S. J., Campbell C. J., Duncan L. J., Irvine W. J. Phytohemagglutinin transformation and circulating lymphocyte subpopulations in insulin-dependent diabetic patients. Diabetes. 1974 Aug;23(8):708–712. doi: 10.2337/diab.23.8.708. [DOI] [PubMed] [Google Scholar]
  71. Mackaness G. B., Lagrange P. H., Miller T. E., Ishibashi T. Feedback inhibition of specifically sensitized lymphocytes. J Exp Med. 1974 Mar 1;139(3):543–559. doi: 10.1084/jem.139.3.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Mackaness G. B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969 May 1;129(5):973–992. doi: 10.1084/jem.129.5.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Maddison S. E., Geiger S. J., Kagan I. G. Schistosoma mansoni: immunity in Macaca mulatta. Exp Parasitol. 1971 Jun;29(3):463–479. doi: 10.1016/0014-4894(71)90056-7. [DOI] [PubMed] [Google Scholar]
  74. Mahmoud A. A., Rodman H. M., Mandel M. A., Warren K. S. Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunologic responses. Granuloma formation, delayed dermal reactivity and allograft rejection. J Clin Invest. 1976 Feb;57(2):362–367. doi: 10.1172/JCI108287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Mahmoud A. A., Warren K. S., Graham R. C., Jr Antieosinophil serum and the kinetics of eosinophilia in Schistosomiasis mansoni. J Exp Med. 1975 Sep 1;142(3):560–574. doi: 10.1084/jem.142.3.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Marcus P. I., Salb J. M. Molecular basis of interferon action: inhibition of viral RNA translation. Virology. 1966 Nov;30(3):502–516. doi: 10.1016/0042-6822(66)90126-7. [DOI] [PubMed] [Google Scholar]
  77. Mauel J., Behin R. Cell-mediated and humoral immunity to protozoan infections. Transplant Rev. 1974;19(0):121–146. doi: 10.1111/j.1600-065x.1974.tb00130.x. [DOI] [PubMed] [Google Scholar]
  78. McGee Z. A., Schaffner W., Koenig M. G. Superinfection in lymphoreticular diseases. Annu Rev Med. 1971;22:25–38. doi: 10.1146/annurev.me.22.020171.000325. [DOI] [PubMed] [Google Scholar]
  79. Menon M., Jaroslow R. N., Koesterer R. The decline of cell-mediated immunity in aging mice. J Gerontol. 1974 Sep;29(5):499–505. doi: 10.1093/geronj/29.5.499. [DOI] [PubMed] [Google Scholar]
  80. Meredith P., Tittor W., DeLima M. G., Walford R. L. Age-related changes in the cellular immune response of lymph node and thymus cells in long-lived mice. Cell Immunol. 1975 Aug;18(2):324–330. doi: 10.1016/0008-8749(75)90060-x. [DOI] [PubMed] [Google Scholar]
  81. Merigan T. C. Host defenses against viral disease. N Engl J Med. 1974 Feb 7;290(6):323–329. doi: 10.1056/NEJM197402072900608. [DOI] [PubMed] [Google Scholar]
  82. Merigan T. C., Reed S. E., Hall T. S., Tyrrell D. A. Inhibition of respiratory virus infection by locally applied interferon. Lancet. 1973 Mar 17;1(7803):563–567. doi: 10.1016/s0140-6736(73)90714-9. [DOI] [PubMed] [Google Scholar]
  83. Munster A. M., Leary A. G., Wilson R. A., Greenberg S. A. Cell-mediated immunity in the uremic rat. Int Arch Allergy Appl Immunol. 1975;48(2):294–298. doi: 10.1159/000231315. [DOI] [PubMed] [Google Scholar]
  84. Newberry W. M., Sanford J. P. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum. J Clin Invest. 1971 Jun;50(6):1262–1271. doi: 10.1172/JCI106604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. North R. J., Kirstein D. P., Tuttle R. L. Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection. J Exp Med. 1976 Mar 1;143(3):559–573. doi: 10.1084/jem.143.3.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. North R. J. Suppression of cell-mediated immunity to infection by an antimitotic drug. Further evidence that migrant macrophages express immunity. J Exp Med. 1970 Sep 1;132(3):535–545. doi: 10.1084/jem.132.3.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Notkins A. L. Immune mechanisms by which the spread of viral infections is stopped. Cell Immunol. 1974 Mar 30;11(1-3):478–483. doi: 10.1016/0008-8749(74)90045-8. [DOI] [PubMed] [Google Scholar]
  88. Ogilvie B. M., Love R. J. Co-operation between antibodies and cells in immunity to a nematode parasite. Transplant Rev. 1974;19(0):147–169. doi: 10.1111/j.1600-065x.1974.tb00131.x. [DOI] [PubMed] [Google Scholar]
  89. Palmer D. L., Reed W. P. Delayed hypersensitivity skin testing. II. Clinical correlates and anergy. J Infect Dis. 1974 Aug;130(2):138–143. doi: 10.1093/infdis/130.2.138. [DOI] [PubMed] [Google Scholar]
  90. Pearson M. N., Raffel S. Macrophage-digested antigen as inducer of delayed hypersensitivity. J Exp Med. 1971 Mar 1;133(3):494–505. doi: 10.1084/jem.133.3.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Pike M. C., Snyderman R. Augmentation of human monocyte chemotactic response by levamisole. Nature. 1976 May 13;261(5556):136–137. doi: 10.1038/261136a0. [DOI] [PubMed] [Google Scholar]
  92. Rager-Zisman B., Bloom B. R. Immunological destruction of herpes simplex virus I infected cells. Nature. 1974 Oct 11;251(5475):542–543. doi: 10.1038/251542a0. [DOI] [PubMed] [Google Scholar]
  93. Rager-Zisman B., Grose C., Bloom B. R. Mechanism of selective nonspecific cell-mediated cytotoxicity of virus-infected cells. Nature. 1976 Mar 25;260(5549):369–370. doi: 10.1038/260369a0. [DOI] [PubMed] [Google Scholar]
  94. Rees J. C., Rossio J. L., Wilson H. E., Minton J. P., Dodd M. C. Cellular immunity in neoplasia. Antigen and mitogen responses in patients with bronchiogenic carcinoma. Cancer. 1975 Dec;36(6):2010–2015. doi: 10.1002/cncr.2820360913. [DOI] [PubMed] [Google Scholar]
  95. Remington J. S., Krahenbuhl J. L., Mendenhall J. W. A role for activated macrophages in resistance to infection with Toxoplasma. Infect Immun. 1972 Nov;6(5):829–834. doi: 10.1128/iai.6.5.829-834.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Rinehart J. J., Balcerzak S. P., Sagone A. L., LoBuglio A. F. Effects of corticosteroids on human monocyte function. J Clin Invest. 1974 Dec;54(6):1337–1343. doi: 10.1172/JCI107880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Rocklin R. E., MacDermott R. P., Chess L., Schlossman S. F., David J. R. Studies on mediator production by highly purified human T and B lymphocytes. J Exp Med. 1974 Nov 1;140(5):1303–1316. doi: 10.1084/jem.140.5.1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Ruben F. L., Winkelstein A., Fotiadis I. G. Immunological responsiveness of tuberculosis patients receiving rifampin. Antimicrob Agents Chemother. 1974 Apr;5(4):383–387. doi: 10.1128/aac.5.4.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Ruskin J., McIntosh J., Remington J. S. Studies on the mechanisms of resistance to phylogenetically diverse intracellular organisms. J Immunol. 1969 Aug;103(2):252–259. [PubMed] [Google Scholar]
  100. Ruskin J., Remington J. S. Toxoplasmosis in the compromised host. Ann Intern Med. 1976 Feb;84(2):193–199. doi: 10.7326/0003-4819-84-2-193. [DOI] [PubMed] [Google Scholar]
  101. Rühl H., Vogt W., Bochert G., Schmidt S., Schaoua H., Moelle R. Lymphocyte transformation and production of a human mononuclear leucocyte chemotactic factor in patients with Hodgkin's disease. Clin Exp Immunol. 1974 Jul;17(3):407–415. [PMC free article] [PubMed] [Google Scholar]
  102. Schatz M., Patterson R., Kloner R., Falk J. The prevalence of tuberculosis and positive tuberculin skin tests in a steroid-treated asthmatic population. Ann Intern Med. 1976 Mar;84(3):261–265. doi: 10.7326/0003-4819-84-3-261. [DOI] [PubMed] [Google Scholar]
  103. Scheinberg M., Blacklow N. R., Goldstein A. L., Parrino T. A., Rose F. B., Cathcart E. S. Influenza: response of T-cell lymphopenia to thymosin. N Engl J Med. 1976 May 27;294(22):1208–1211. doi: 10.1056/NEJM197605272942204. [DOI] [PubMed] [Google Scholar]
  104. Slade M. S., Simmons R. L., Yunis E., Greenberg L. J. Immunodepression after major surgery in normal patients. Surgery. 1975 Sep;78(3):363–372. [PubMed] [Google Scholar]
  105. Spitler L. E., Levin A. S., Stites D. P., Fudenberg H. H., Pirofsky B., August C. S., Stiehm E. R., Hitzig W. H., Gatti R. A. The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest. 1972 Dec;51(12):3216–3224. doi: 10.1172/JCI107148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Stanley E. D., Jackson G. G., Dirda V. A., Rubenis M. Effect of a topical interferon inducer on rhinovirus infections in volunteers. J Infect Dis. 1976 Jun;133 (Suppl):A121–A127. doi: 10.1093/infdis/133.supplement_2.a121. [DOI] [PubMed] [Google Scholar]
  107. Stavy L., Cohen I. R., Feldman M. The effect of hydrocortisone on lymphocyte-mediated cytolysis. Cell Immunol. 1973 May;7(2):302–312. doi: 10.1016/0008-8749(73)90252-9. [DOI] [PubMed] [Google Scholar]
  108. Stevens D. A., Jordan G. W., Waddell T. F., Merigan T. C. Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial. N Engl J Med. 1973 Oct 25;289(17):873–878. doi: 10.1056/NEJM197310252891701. [DOI] [PubMed] [Google Scholar]
  109. Stevens D. A., Merigan T. C. Interferon, antibody, and other host factors in herpes zoster. J Clin Invest. 1972 May;51(5):1170–1178. doi: 10.1172/JCI106910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Stewart R. H., Hodge F. A., Silverman M. S. Effects of continuous irradiation of mice on the immune response to live Listeria monocytogenes. J Infect Dis. 1967 Apr;117(2):109–115. doi: 10.1093/infdis/117.2.109. [DOI] [PubMed] [Google Scholar]
  111. Stobo J. D., Paul S., Van Scoy R. E., Hermans P. E. Suppressor thymus-derived lymphocytes in fungal infection. J Clin Invest. 1976 Feb;57(2):319–328. doi: 10.1172/JCI108283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Sullivan J. L., Barry D. W., Lucas S. J., Albrecht P. Measles infection of human mononuclear cells. I. Acute infection of peripheral blood lymphocytes and monocytes. J Exp Med. 1975 Sep 1;142(3):773–784. doi: 10.1084/jem.142.3.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Sundmacher R., Neumann-Haefelin D., Manthey K. F., Müller O. Interferon in treatment of dendritic keratitis in humans: a preliminary report. J Infect Dis. 1976 Jun;133 (Suppl):A160–A164. doi: 10.1093/infdis/133.supplement_2.a160. [DOI] [PubMed] [Google Scholar]
  114. Symoens J., Brugmans J. Letter: Treatment of recurrent aphthous stomatitis and herpes with levamisole. Br Med J. 1974 Dec 7;4(5944):592–592. doi: 10.1136/bmj.4.5944.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Tripodi D., Parks L. C., Brugmans J. Drug-induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer. N Engl J Med. 1973 Aug 16;289(7):354–357. doi: 10.1056/NEJM197308162890707. [DOI] [PubMed] [Google Scholar]
  116. Twomey J. J., Laughter A. H., Farrow S., Douglass C. C. Hodgkin's disease. An immunodepleting and immunosuppressive disorder. J Clin Invest. 1975 Aug;56(2):467–475. doi: 10.1172/JCI108113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Van Eygen M., Znamensky P. Y., Heck E., Raymaekers I. Levamisole in prevention of recurrent upper-respiratory-tract infections in children. Lancet. 1976 Feb 21;1(7956):382–385. doi: 10.1016/s0140-6736(76)90214-2. [DOI] [PubMed] [Google Scholar]
  118. Versijp G., van Zwet T. L., van Furth R. Letter: Levamisole and functions of peritoneal macrophages. Lancet. 1975 Apr 5;1(7910):798–798. doi: 10.1016/s0140-6736(75)92457-5. [DOI] [PubMed] [Google Scholar]
  119. Visakorpi R. Effect of irradiation on established delayed hypersensitivity. Suppression of skin reactions, recovery and the effect of cell transfer. Acta Pathol Microbiol Scand B Microbiol Immunol. 1972;80(6):788–794. [PubMed] [Google Scholar]
  120. Ward P. A., Berenberg J. L. Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator. N Engl J Med. 1974 Jan 10;290(2):76–80. doi: 10.1056/NEJM197401102900203. [DOI] [PubMed] [Google Scholar]
  121. Warren K. S. Regulation of the prevalence and intensity of schistosomiasis in man: immunology or ecology? J Infect Dis. 1973 May;127(5):595–609. doi: 10.1093/infdis/127.5.595. [DOI] [PubMed] [Google Scholar]
  122. Webster L. T., Jr, Butterworth A. E., Mahmoud A. A., Mngola E. N., Warren K. S. Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole. N Engl J Med. 1975 May 29;292(22):1144–1147. doi: 10.1056/NEJM197505292922202. [DOI] [PubMed] [Google Scholar]
  123. White A. Nature and biological activities of thymus hormones: prospects for the future. Ann N Y Acad Sci. 1975 Feb 28;249:523–530. doi: 10.1111/j.1749-6632.1975.tb29101.x. [DOI] [PubMed] [Google Scholar]
  124. Winkelstein A. Effects of cytotoxic immunosuppressants on tuberculin-sensitive lymphocytes in guinea pigs. J Clin Invest. 1975 Dec;56(6):1587–1596. doi: 10.1172/JCI108241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Wolfe M. S., Louria D. B., Armstrong D., Blevins A. Salmonellosis in patients with neoplastic disease. A review of 100 episodes at Memorial Cancer Center over a 13-year period. Arch Intern Med. 1971 Oct;128(4):546–554. doi: 10.1001/archinte.128.4.546. [DOI] [PubMed] [Google Scholar]
  126. Young R. C., Corder M. P., Haynes H. A., DeVita V. T. Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am J Med. 1972 Jan;52(1):63–72. doi: 10.1016/0002-9343(72)90008-3. [DOI] [PubMed] [Google Scholar]
  127. Ziegler H. D., Ziegler P. B. Depression of tuberculin reaction in mild and moderate protein-calorie malnourished children following BCG vaccination. Johns Hopkins Med J. 1975 Aug;137(2):59–64. [PubMed] [Google Scholar]
  128. Zinkernagel R. M., Doherty P. C. Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis. Nature. 1974 Oct 11;251(5475):547–548. doi: 10.1038/251547a0. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES